Australian Clinical Labs
ACL.AX
#8117
Rank
โ‚น24.25 B
Marketcap
โ‚น127.43
Share price
-3.48%
Change (1 day)
-20.22%
Change (1 year)

Revenue for Australian Clinical Labs (ACL.AX)

Revenue in 2025: โ‚น45.35 Billion

According to Australian Clinical Labs's latest financial reports the company's current revenue (TTM ) is โ‚น45.35 Billion. In 2025 the company made a revenue of โ‚น45.35 Billion an increase over the revenue in the year 2024 that were of โ‚น43.11 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Australian Clinical Labs from 2021 to 2025

Annual revenue

Year Revenue Change
2025โ‚น45.35 B5.2%
2024โ‚น43.11 B-0.2%
2023โ‚น43.19 B-32.41%
2022โ‚น63.90 B41.91%
2021โ‚น45.03 B